Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118333112 | 11833311 | 2 | F | 20160906 | 20151214 | 20160906 | EXP | GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-085481 | BRISTOL MYERS SQUIBB | 24.00 | YR | M | Y | 81.18000 | KG | 20160906 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118333112 | 11833311 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 2 MG, UNK | N | 21436 | 2 | MG | |||||||
| 118333112 | 11833311 | 2 | SS | MINOXIDIL. | MINOXIDIL | 1 | Topical | 50 MG, UNK | N | 0 | 50 | MG | |||||||
| 118333112 | 11833311 | 3 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG, UNK | N | 0 | 20 | MG | |||||||
| 118333112 | 11833311 | 4 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | 4 MG, UNK | N | 0 | 4 | MG | |||||||
| 118333112 | 11833311 | 5 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | Unknown | U | 0 | ||||||||||
| 118333112 | 11833311 | 6 | C | ZOPICLONE | ZOPICLONE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118333112 | 11833311 | 1 | Depression |
| 118333112 | 11833311 | 2 | Alopecia |
| 118333112 | 11833311 | 3 | Dyspepsia |
| 118333112 | 11833311 | 4 | Acute psychosis |
| 118333112 | 11833311 | 5 | Product used for unknown indication |
| 118333112 | 11833311 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118333112 | 11833311 | DS |
| 118333112 | 11833311 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118333112 | 11833311 | Aggression | |
| 118333112 | 11833311 | Alopecia | |
| 118333112 | 11833311 | Blindness | |
| 118333112 | 11833311 | Condition aggravated | |
| 118333112 | 11833311 | Confusional state | |
| 118333112 | 11833311 | Eye irritation | |
| 118333112 | 11833311 | Feeling abnormal | |
| 118333112 | 11833311 | Hypersensitivity | |
| 118333112 | 11833311 | Intellectual disability | |
| 118333112 | 11833311 | Laziness | |
| 118333112 | 11833311 | Mental impairment | |
| 118333112 | 11833311 | Palpitations | |
| 118333112 | 11833311 | Penis disorder | |
| 118333112 | 11833311 | Product use issue | |
| 118333112 | 11833311 | Restless legs syndrome | |
| 118333112 | 11833311 | Skin burning sensation | |
| 118333112 | 11833311 | Skin exfoliation | |
| 118333112 | 11833311 | Skin wrinkling | |
| 118333112 | 11833311 | Speech disorder | |
| 118333112 | 11833311 | Tardive dyskinesia | |
| 118333112 | 11833311 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118333112 | 11833311 | 1 | 20150805 | 20150810 | 0 | |
| 118333112 | 11833311 | 2 | 20150202 | 20150205 | 0 | |
| 118333112 | 11833311 | 4 | 20150418 | 20150801 | 0 |